메뉴 건너뛰기




Volumn 40, Issue 1, 2008, Pages 263-266

Lipid Profiles of Patients With a Transplanted Heart Before and After the Operation

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; GEMFIBROZIL; METHYLPREDNISOLONE;

EID: 38749096630     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.11.043     Document Type: Article
Times cited : (7)

References (16)
  • 1
    • 0026740158 scopus 로고
    • Transplant coronary artery disease: non immunologic risk factors
    • Johnson M. Transplant coronary artery disease: non immunologic risk factors. J Heart Lung Transplant 11 S124 (1992) 32
    • (1992) J Heart Lung Transplant , vol.11 , Issue.SUPPL.124 , pp. 32
    • Johnson, M.1
  • 2
    • 0343410759 scopus 로고
    • The Australian Cardiothoracic Organ Transplant Registry: first report 1984-1992
    • Keogh A., and Kaan A. The Australian Cardiothoracic Organ Transplant Registry: first report 1984-1992. Aust N Z J Med 22 (1992) 712
    • (1992) Aust N Z J Med , vol.22 , pp. 712
    • Keogh, A.1    Kaan, A.2
  • 4
    • 0029119711 scopus 로고
    • Effect of pravastatin on outcomes after cardiac transplantation
    • Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621
    • (1995) N Engl J Med , vol.333 , pp. 621
    • Kobashigawa, J.A.1    Katznelson, S.2    Laks, H.3
  • 5
    • 0031654546 scopus 로고    scopus 로고
    • Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
    • Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744
    • (1998) J Heart Lung Transplant , vol.17 , pp. 744
    • Costanzo, M.R.1    Naftel, D.C.2    Pritzker, M.R.3
  • 6
    • 0029161742 scopus 로고
    • Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy
    • McManus B.M., Horley K.J., Wilson J.E., et al. Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 147 (1995) 293
    • (1995) Am J Pathol , vol.147 , pp. 293
    • McManus, B.M.1    Horley, K.J.2    Wilson, J.E.3
  • 7
    • 0033877290 scopus 로고    scopus 로고
    • Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin
    • Magnani G., Carinci V., Magelli C., et al. Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin. J Heart Lung Transplant 19 (2000) 710
    • (2000) J Heart Lung Transplant , vol.19 , pp. 710
    • Magnani, G.1    Carinci, V.2    Magelli, C.3
  • 8
    • 0037422562 scopus 로고    scopus 로고
    • Simvastatin initiated early after heart transplantation: 8-year prospective experience
    • Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 107 (2003) 93
    • (2003) Circulation , vol.107 , pp. 93
    • Wenke, K.1    Meiser, B.2    Thiery, J.3
  • 9
    • 0025200422 scopus 로고
    • Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2
    • Cutts J.L., and Bankhurst A.D. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2. J Cell Physiol 145 (1990) 244
    • (1990) J Cell Physiol , vol.145 , pp. 244
    • Cutts, J.L.1    Bankhurst, A.D.2
  • 10
    • 0023839115 scopus 로고
    • Myolisis and acute renal failure in a heart transplant recipent receiving lovastatin
    • (letter)
    • Norman D.J., Illingworth D.R., Munson J., et al. Myolisis and acute renal failure in a heart transplant recipent receiving lovastatin. (letter). N Engl J Med 318 (1988) 46
    • (1988) N Engl J Med , vol.318 , pp. 46
    • Norman, D.J.1    Illingworth, D.R.2    Munson, J.3
  • 11
    • 29544433421 scopus 로고    scopus 로고
    • Safety of statins when response is carefully monitored: a study of 336 heart recipients
    • Marzoa-Rivas R., Crespo-Leiro M.G., Paniaguna-Marin M.J., et al. Safety of statins when response is carefully monitored: a study of 336 heart recipients. Transplant Proc 37 (2005) 4071
    • (2005) Transplant Proc , vol.37 , pp. 4071
    • Marzoa-Rivas, R.1    Crespo-Leiro, M.G.2    Paniaguna-Marin, M.J.3
  • 12
    • 33847375619 scopus 로고    scopus 로고
    • Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients
    • Patel A.R., Ambrose M.S., Doffy G.A., et al. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients. J Heart Lung Transplant 26 (2007) 281
    • (2007) J Heart Lung Transplant , vol.26 , pp. 281
    • Patel, A.R.1    Ambrose, M.S.2    Doffy, G.A.3
  • 13
    • 19544371758 scopus 로고    scopus 로고
    • Ezetimibe: a review of it's metabolism, pharmacokinetics, and drug interactions
    • Kosoglou T., Statkevich P., Johnson Levonas A.J., et al. Ezetimibe: a review of it's metabolism, pharmacokinetics, and drug interactions. Clin Pharmacokinet 44 (2005) 467
    • (2005) Clin Pharmacokinet , vol.44 , pp. 467
    • Kosoglou, T.1    Statkevich, P.2    Johnson Levonas, A.J.3
  • 14
    • 0033930458 scopus 로고    scopus 로고
    • Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients
    • Chin C., Rosenthal D., and Bernstein D. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. Pediatr Transplant 4 (2000) 193
    • (2000) Pediatr Transplant , vol.4 , pp. 193
    • Chin, C.1    Rosenthal, D.2    Bernstein, D.3
  • 15
    • 0036845850 scopus 로고    scopus 로고
    • Efficacy and safety of atorvastatin after pediatric heart transplantation
    • Chin C., Gamberg P., Miller J., et al. Efficacy and safety of atorvastatin after pediatric heart transplantation. J Heart Lung Transplant 21 (2002) 1213
    • (2002) J Heart Lung Transplant , vol.21 , pp. 1213
    • Chin, C.1    Gamberg, P.2    Miller, J.3
  • 16
    • 11844286845 scopus 로고    scopus 로고
    • Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation
    • Mahle W.T., Vincent R.N., Berg A.M., et al. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J Heart Lung Transplant 24 (2005) 63
    • (2005) J Heart Lung Transplant , vol.24 , pp. 63
    • Mahle, W.T.1    Vincent, R.N.2    Berg, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.